Med-tech start-up 52 North Health has raised £1 million in its first round of funding to help it develop the NeutroCheck, a fully-integrated clinical, AI and medical device-based system for people living with cancer.  

RegGenome, a commercial spin-out from the University of Cambridge, has announced the completion of a $6 million seed funding round.

Cambridge Enterprise, the commercialisation arm of the University of Cambridge, has announced the appointment of Dr Christine Martin as Head of Seed Funds.

BKwai, a construction data company that helps engineers develop smarter, more sustainable infrastructure, has raised £2.2 million in seed funding from investors led by Octopus Ventures with participation from Cambridge Enterprise and Deeptech Labs.

Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million) to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that cause SARS and MERS.

A University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies make better medicines, faster. It announced today that it has closed a £2.14 million seed funding round.

Zero-carbon refrigeration pioneer Barocal has secured a £1.3 million investment to accelerate commercialisation of its novel technology designed to cut global CO₂ emissions. As the technology also works in heating applications, the University of Cambridge spin-out now plans to explore the potential of its breakthrough for domestic and commercial heating systems—to provide a cost-effective, efficient alternative to expensive air source heat pumps.

Cambridge spin-out Zetta Genomics has raised £2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its genomic data management technology and power the discovery and delivery of precision medicine at scale.